Replies to post #112017 on Biotech Values

[Jonathan Robinson]

900,000 volume equiv in puts for Jan/Feb vs 800,000 volume. Put prices still flying. Wide market.

Jon

[ronpopeil]

Teva CEO doesn't see impending approval for launch of generic Copaxone
These comments were made at the Goldman Sachs CEO Conference. :theflyonthewall.com